Application

18988719 · RNAi Agents for Inhibiting Expression of Activin Receptor-Like Kinase 7 (ALK7), Compositions Thereof, and Methods of Use

Filed 2024-12-19 · Granted · Patent 12442002 (2025-10-14) The official file ↗The patent and its PDF ↗ · Art unit 1637 · Examiner John Charles McKillop Typical · CPC C12N 15/111 · Arrowhead Pharmaceuticals, Inc. · Arrowhead Pharmaceuticals, Inc.

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

3.1 mo

to disposition 9.8 mo

Statutes raised

103 112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.